SC 13G Filing

Company

NYMOX PHARMACEUTICAL CORP

Filed

August 26, 2002

Accession Number

0001180049-02-000008

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →